Fuxiang Zhou
机构：Wuhan University, Zhongnan Hospital of Wuhan University, Hubei Cancer Hospital · ORCID：0000-0001-5472-2306
发表论文 103 篇 · 总被引 1879 次 · h-index 28
代表论文
- Bifidobacterium modulation of tumor immunotherapy and its mechanism (2024 · Cancer Immunology Immunotherapy · 被引 61)
- Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial (2025 · The Lancet. Gastroenterology & hepatology · 被引 45)
- PD-1/CD80+ small extracellular vesicles from immunocytes induce cold tumours featured with enhanced adaptive immunosuppression (2024 · Nature Communications · 被引 29)
- A Facile Strategy for Multiplex Protein Detection by a Fluorescent Microsphere-Based Digital Immunoassay (2024 · Analytical Chemistry · 被引 20)
- Quantum Dot Reporters Designed for CRISPR-Based Detection of Viral Nucleic Acids (2024 · Analytical Chemistry · 被引 16)
- SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer (2024 · Cancer Immunology Immunotherapy · 被引 15)